- Release Date: 15/11/21 09:33
- Summary: IRB approval for US COVID-19 study modification
- Price Sensitive: Yes
- Download Document 112.12KB
- Forums
- ASX - By Stock
- RAP
- Ann: IRB approval for US COVID-19 study modification
Ann: IRB approval for US COVID-19 study modification
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)